WHO ICTRP trial
Use of drug therapy in the management of symptomatic ureteric stones in…
EUCTR2010-019469-26-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019469-26-GB |
|---|---|
| Public title | Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine)and an alpha blocker(tamsulosin) - The SUSPEND trial - Symptomatic ureteric stone passage enabled by drugs (SUSPEND) |
| Scientific title | Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine)and an alpha blocker(tamsulosin) - The SUSPEND trial - Symptomatic ureteric stone passage enabled by drugs (SUSPEND) |
| Primary sponsor | University of Aberdeen |
| Secondary sponsors | NHS Grampian |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | United Kingdom |
| Conditions | Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine) and an alpha blocker (tamsulosin). |
| Interventions | Trade Name: Petyme MR Product Name: Tamsulosin Pharmaceutical Form: Capsule* INN or Proposed INN: Tamsulosin CAS Number: 106133-20-4 Concentration unit: µg microgram(s) Concentration type: equal Concentration number: 400- Trade Name… |
| Registration date | Jun 18, 2010 |
| Target size | 1200 |
| Secondary IDs | pRGF/016/09 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: